Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers

Blood Adv (2020) 4 (4): 728–739.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals